Trial to Evaluate the Safety and Pharmacokinetics of HMPL-689 in Patients With Lymphomas
Clinical trial NCT03786926 · TERMINATED
Trial details
- NCT number
- NCT03786926
- Sponsor
- Hutchmed
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-26
- Primary completion
- 2024-06-26
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.